- The key vendors in the Global Blood Glucose Monitoring Device Market 2014-2018 are Abbott Laboratories Ltd., Arkray Inc., Bayer HealthCare AG, F. Hoffmann-La Roche Ltd. and LifeScan Inc.
London, 28 October 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Blood Glucose Monitoring Device Market 2014-2018. One key trend emerging in the market is the change in the preference of patients to take advantage of home healthcare rather than going to hospitals. The move toward proactive monitoring rather than waiting for treatment is opening up new opportunities for the Global BGM Device market. The market is expected to post a CAGR of 5.26 percent during the period 2013-2018.
“Vendors in the Global BGM Device market are adopting product bundling strategies, where two or more products or services are combined together to achieve product differentiation and to provide better product offerings,” says Faisal Ghaus, Vice President of TechNavio Research.
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
